Publikationen von W. Wurst

Poët, M.; Kornak, U.; Schweizer, M.; Zdebik, A. A.; Scheel, O.; Hoelter, S.; Wurst, W.; Schmitt, A.; Fuhrmann, J. C.; Planells-Cases, R. et al.; Mole, S. E.; Hübner, C. A.; Jentsch, T. J.: Lysosomal storage disease upon disruption of the neuronal chloride transport protein CIC-6. Proceedings of the National Academy of Sciences of the United States of America 103 (37), S. 13854 - 13859 (2006)

Galy, B.; Hölter, S. M.; Klopstock, T.; Ferring, D.; Becker, L.; Kaden, S.; Wurst, W.; Gröne, H. J.; Hentze, M. W.: Iron homeostasis in the brain: complete iron regulatory protein 2 deficiency without symptomatic neurodegeneration in the mouse. Nature Genetics 38 (9), S. 967 - 969 (2006)

Jukkola, T.; Lahti, L.; Naserke, T.; Wurst, W.; Partanen, J.: FGF regulated gene-expression and neuronal differentiation in the developing midbrain-hindbrain region. Developmental Biology 297 (1), S. 141 - 157 (2006)

Prakash, N.; Wurst, W.: Genetic networks controlling the development of midbrain dopaminergic neurons. Journal of Physiology-London 575 (2), S. 403 - 410 (2006)

Guimera, J.; Vogt-Weisenhorn, D.; Echevarria, D.; Martinez, S.; Wurst, W.: Molecular characterization, structure and developmental expression of Megane bHLH factor. Gene 377, S. 65 - 76 (2006)

Borgkvist, A.; Puelles, E.; Carta, M.; Acampora, D.; Ang, S. L.; Wurst, W.; Goiny, M.; Fisone, G.; Simeone, A.; Usiello, A.: Altered dopaminergic innervation and amphetamine response in adult Otx2 conditional mutant mice. Molecular and Cellular Neuroscience 31 (2), S. 293 - 302 (2006)

De-Zolt, S.; Schnütgen, F.; Seisenberger, C.; Hansen, J.; Hollatz, M.; Floss, T.; Ruiz, P.; Wurst, W.; von Melchner, H.: High-throughput trapping of secretory pathway genes in mouse embryonic stem cells. Nucleic Acids Research 34 (3), e25 (2006)

Papazoglou, A.; Hackl, C.; Klein, A.; Prakash, N.; Wurst, W.; Nikkhah, G.: In vivo characterization of embryonic dopaminergic neurons derived from transgenic mice ectopically expressing Otx2 in the anterior hindbrain. Cell Transplantation 15 (6), S. 551 - 552 (2006)

Prakash, N.; Brodski, C.; Naserke, T.; Puelles, E.; Gogoi, R.; Hall, A.; Panhuysen, M.; Echevarria, D.; Sussel, L.; Vogt Weisenhorn, D. M. et al.; Martinez, S.; Arenas, E.; Simeone, A.; Wurst, W.: A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo. Development 133 (1), S. 89 - 98 (2006)

Schmidt, M. V.; Deussing, J. M.; Oitzl, M. S.; Ohl, F.; Levine, S.; Wurst, W.; Holsboer, F.; Müller, M. B.; de Kloet, E. R.: Differential disinhibition of the neonatal hypothalamic-pituitary-adrenal axis in brain-specific CRH receptor 1-knockout mice. European Journal of Neuroscience 24, S. 2291 - 2298 (2006)

Hitz, C.; Vogt-Weisenhorn, D.; Ruiz, P.; Wurst, W.; Floss, T.: Progressive loss of the spongiotrophoblast layer of Birc6/Bruce mutants results in embryonic lethality (vol 42, pg 91, 2005). Genesis 43 (4), S. 216 - 216 (2005)

Breu, J.; Deussing, J. M.; Wurst, W.: CRHR-1 signalling inhibits AMPA-receptor internalisation. Pharmacopsychiatry 38 (5), S. 232 - 232 (2005)

Deussing, J. M.; Kühne, C.; Panhuysen, M.; Pütz, B.; Breu, J.; Paez-Pereda, M.; Holsboer, F.; Wurst, W.: Gene expression profiling reveals corticotropin-releasing hormone (CRH) dependent signaling pathways. Pharmacopsychiatry 38 (5), S. 236 - 236 (2005)

Lu, A.; Steiner, M.; Engelholm, M.; Engelholm, M.; Wotjak, C. T.; Holsboer, F.; Wurst, W.; Deussing, J. M.: Site-specific overexpression of corticotropin-releasing hormone (CRH) in the mouse brain - modelling central CRH system hyperactivity. Pharmacopsychiatry 38 (5), S. 261 - 261 (2005)

Singewald, N.; Nguyen, N. K.; Hetzenauer, A.; Thöringer, C. K.; Wurst, W.; Deussing, J.; Müller, M. B.; Holsboer, F.; Keck, M. E.: Conditional Crh1 receptor knockout mice show altered neuronal activation pattern to mild anxiogenic challenge. Journal of Neurochemistry 94 (Suppl. 2), S. 230 - 230 (2005)

Blak, A. A.; Naserke, T.; Vogt Weisenhorn, D. M.; Prakash, N.; Partanen, J.; Wurst, W.: Expression of Fgf receptors 1, 2, and 3 in the developing mid- and hindbrain of the mouse. Developmental Dynamics 233 (3), S. 1023 - 1030 (2005)

Gailus-Durner, V.; Fuchs, H.; Becker, L.; Bolle, I.; Brielmeier, M.; Calzada-Wack, J.; Evert, R.; Ehrhardt, N.; Dalkel, C.; Franz, T. J. et al.; Grundner-Culemann, E.; Hammelbacher, S.; Hölter, S. M.; Hölzlwimmer, G.; Horsch, M.; Javaheri, A.; Kataydjiev, S. V.; Klempt, M.; Kling, E.; Kunder, S.; Lengger, C.; Lisse, T.; Mijalski, T.; Naton, B.; Pedersen, V.; Prehn, C.; Przemeck, G.; Racz, I.; Reinhard, C.; Reitmeir, P.; Schneider, I.; Schrewe, A.; Steinkamp, R.; Zybill, C.; Adamski, J.; Beckers, J.; Behrendt, H.; Favor, J.; Graw, J.; Heldmaier, G.; Höfler, H.; Ivandic, B.; Katus, H.; Kirchhof, P.; Klingenspor, M.; Klopstock, T.; Lengeling, A.; Müller, W.; Ohl, F.; Ollert, M.; Quintanilla-Martinez, L.; Schmidt, J.; Schulz, H.; Wolf, E.; Wurst, W.; Zimmer, A.; Busch, D. H.; de Angelis, M. H.: Introducing the German Mouse Clinic: open access platform for standardized phenotyping. Nature Methods 2 (6), S. 403 - 404 (2005)

Hitz, C.; Vogt-Weisenhorn, D.; Ruiz, P.; Wurst, W.; Floss, T.: Progressive loss of the spongiotrophoblast layer of Birc6/Bruce mutants results in embryonic lethality. Genesis 42 (2), S. 91 - 103 (2005)

Refojo, D.; Echenique, C.; Müller, M. B.; Reul, J. M. H. M.; Deussing, J. M.; Wurst, W.; Sillaber, I.; Paez-Pereda, M.; Holsboer, F.; Arzt, E.: Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas. Proceedings of the National Academy of Sciences of the United States of America 102 (17), S. 6183 - 6188 (2005)

Jakupoglu, C.; Przemeck, G. K. H.; Schneider, M.; Moreno, S. G.; Mayr, N.; Hatzopoulos, A. K.; de Angelis, M. H.; Wurst, W.; Bornkamm, G. W.; Brielmeier, M. et al.; Conrad, M.: Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development. Molecular and Cellular Biology 25 (5), S. 1980 - 1988 (2005)